Clinical Trials for Ocugen

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Ocugen

Clinical Trials (6)

NCT06388200
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa
PHASE3Recruiting
150 participants
Started: Jun 18, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor17 locations
NCT05802329
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
PHASE1Recruiting
30 participants
Started: Jan 13, 2024 · Completed: Jul 31, 2026
2 conditions1 sponsor5 locations
NCT05904691
Safety and Tolerability of OCU-10-C-110 for Injection in Subjects With Neovascular Age-related Macular Degeneration
PHASE1Recruiting
19 participants
Started: Nov 1, 2023 · Completed: Nov 30, 2026
1 condition1 sponsor3 locations
NCT05956626
A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
PHASE2/PHASE3Recruiting
51 participants
Started: Aug 25, 2023 · Completed: Sep 28, 2026
1 condition1 sponsor14 locations
NCT06018558
Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy
PHASE1/PHASE2Active, not recruiting
60 participants
Started: Feb 23, 2023 · Completed: May 29, 2026
1 condition1 sponsor12 locations
NCT05203939
Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis
PHASE1/PHASE2Active, not recruiting
22 participants
Started: Jan 24, 2022 · Completed: Mar 31, 2027
2 conditions1 sponsor7 locations